SCHEMBL6696960

SCHEMBL6696960

NC(=O)c1cccc2c1c1c(O)cccc1n2Cc1cccc(Oc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.47
SIRT2 Q8IXJ6 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
FAAH O00519 4/20 0.43
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
F10 P00742 1/20 0.40
MGLL Q99685 1/20 0.40
PLA2G10 O15496 1/20 0.40
CTNNB1 P35222 1/20 0.40
CCR8 P51685 2/20 0.40
TDP1 Q9NUW8 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
SYK P43405 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770280 0.91 PLA2G2A (0.40) PLA2G2ASIRT2SIRT1FAAHKDM4E
SCHEMBL6775435 0.90 PLA2G2A (0.40) PLA2G2ASIRT2SIRT1FAAHKDM4E
SCHEMBL6776978 0.90 PLA2G2A (0.42) PLA2G2ASIRT2SIRT1FAAHKDM4E
SCHEMBL13893632 0.88 CCR8 (0.43) PLA2G2ASIRT2SIRT1FAAHKDM4E
SCHEMBL6771968 0.87 PLA2G2A (0.38) PLA2G2ASIRT2SIRT1FAAHKDM4E
SCHEMBL6691213 0.87 FAAH (0.46) PLA2G2AFAAHKDM4EALDH1A1LMNA
SCHEMBL5212989 0.87 PLA2G2A (0.58) PLA2G2AKDM4EALDH1A1SMN1; SMN2F10
SCHEMBL6774857 0.86 FAAH (0.43) PLA2G2AFAAHLMNACCR8
SCHEMBL14394259 0.86 CTNNB1 (0.43) PLA2G2ASIRT2SIRT1FAAHKDM4E
SCHEMBL6776640 0.86 CETP (0.41) PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1378246-B1 sPLA2 INHIBITORS FOR ARTERIOSCLEROSIS SHIONOGI & CO (JP) 2009-04-15 EP disclosed
EP-2044958-A2 Pharmaceutical composition for treating arteriosclerosis Shionogi & Co., Ltd. (JP) 2009-04-08 EP disclosed
EP-0952149-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors LILLY CO ELI (US) 2004-06-09 EP disclosed
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed